Caredx (CDNA)Director sold ~$186K
Peter Maag, Director at Caredx, sold ~$186K of Caredx shares.
- ~$186K
- Approx. value · 10K sh @ $18.58
- 309K
- Holds after · shares reported
- Traded
- Jul 7, 2025
- Filed
- Jul 10, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 6, 2025InsiderDirector sold ~$236K of CDNA shares in the open market
- May 12, 2025InsiderDirector sold ~$465K of CDNA shares in the open market
- May 28, 2025InsiderDirector sold ~$523K of CDNA shares in the open market
- Jun 11, 2025InsiderDirector sold ~$386K of CDNA shares in the open market
- Jun 17, 2025InsiderDirector sold ~$192K of CDNA shares in the open market
- Jun 18, 2025InsiderDirector sold ~$203K of CDNA shares in the open market
- Jul 7, 2025 · this disclosureInsiderDirector sold ~$186K of CDNA shares in the open market
What came next
- Aug 5, 2025InsiderOfficer sold ~$34K of CDNA shares in the open market
- Oct 22, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On and effective as of October 22, 2025, the Board of Directors (the “Board”) or CareDx, Inc. (the “Company”) appointed Suresh Gunasekaran as a Class II director of the Company.”
- Nov 4, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Caredx
For Caredx, OQRO holds 4 fund holdings reports (13F) and 3 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CDNA page.
Other recent filings by Peter Maag, Director
- SEC Form 4 at Caredx (CDNA)Jun 20, 2025
- SEC Form 4 at Caredx (CDNA)May 2, 2025
- SEC Form 4 at Caredx (CDNA)Dec 4, 2024
The full history of Peter Maag, Director is on the profile page.
How this filing works
Other disclosures at Caredx
- USAspending.gov award recordSep 30, 2026
- USAspending.gov award recordSep 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 13, 2026
Everything OQRO holds on this company is on its CDNA page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
